Maze Therapeutics, Inc. (MAZE) Form 8-K Material Events
Maze Therapeutics, Inc. (MAZE) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MAZE
CIK: 1842295
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerMichael Formolo
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-15 | 8-K | 0001193125-26-424067 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0001676170-26-000024 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0002050172-26-000038 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009933 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-29 | 4 Filing | 0002050167-26-000030 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001969223-26-001044 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | 4 Filing | 0002050172-26-000036 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001950047-26-009147 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | 4 Filing | 0001782758-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | 4 Filing | 0002050167-26-000027 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | 4 Filing | 0001676170-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | 4 Filing | 0002050172-26-000034 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001782758-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0002050167-26-000025 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001676170-26-000020 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0002050172-26-000032 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001782758-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0002050167-26-000024 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001676170-26-000019 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0002050172-26-000031 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001969223-26-000973 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-28 | 4 Filing | 0002050167-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 Filing | 0001894117-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 Filing | 0001341161-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-08-17 | 2026-08-13 | 3 Filing | 0001894117-26-000005 | View SEC Doc Filr Page |